CHIKUNGUNYA VIRUS INFECTION
Clinical trials for CHIKUNGUNYA VIRUS INFECTION explained in plain language.
Never miss a new study
Get alerted when new CHIKUNGUNYA VIRUS INFECTION trials appear
Sign up with your email to follow new studies for CHIKUNGUNYA VIRUS INFECTION, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Can a single shot shield children from chikungunya?
⭐️ VACCINE ⭐️ CompletedThis trial is testing whether a single injection of an experimental chikungunya vaccine, VLA1553, is safe and triggers a protective immune response in healthy children aged 1 to 11 years. About 300 children will receive either a full dose, a half dose, or a control vaccine. The s…
Matched conditions: CHIKUNGUNYA VIRUS INFECTION
Phase: PHASE2 • Sponsor: Valneva Austria GmbH • Aim: ⭐️ VACCINE ⭐️
Last updated Aug 15, 2026 00:00 UTC
-
Early safety check for new chikungunya drug
Knowledge-focused CompletedThis early-stage study tested a single dose of an experimental drug called SAR440894 in 42 healthy adults to see if it was safe. The goal was not to treat the disease but to gather initial safety information before testing it in people with chikungunya virus infection. Participan…
Matched conditions: CHIKUNGUNYA VIRUS INFECTION
Phase: PHASE1 • Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:10 UTC